Catalyst Pharmaceutical
CPRX
CPRX
188 hedge funds and large institutions have $459M invested in Catalyst Pharmaceutical in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 61 increasing their positions, 72 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
188
Holders Change
+1
Holders Change %
+0.53%
% of All Funds
3.18%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
23
Increased
61
Reduced
72
Closed
18
Calls
$715K
Puts
$141K
Net Calls
+$574K
Net Calls Change
+$478K
Top Buyers
| 1 |
Millennium Management
New York
|
$19.1M |
| 2 |
State Street
Boston,
Massachusetts
|
$38.1M |
| 3 |
Goldman Sachs
New York
|
$13.4M |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
$10.2M |
| 5 |
Renaissance Technologies
New York
|
$7.23M |
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$8K |
| 2 |
Two Sigma Investments
New York
|
$3.25M |
| 3 |
BlackRock
New York
|
$48.7M |
| 4 |
Wells Fargo
San Francisco,
California
|
$94K |
| 5 |
Man Group
London,
United Kingdom
|
$2.14M |
